rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1994-6-17
|
pubmed:abstractText |
Patients with metastatic breast carcinoma resistant to first line chemotherapy may require further treatment. Results o second line chemotherapy are still largely unsatisfactory. For this reason a phase II study on the combination of mitomycin C and vinorelbine was carried out.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0300-8916
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
28
|
pubmed:volume |
80
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
33-6
|
pubmed:dateRevised |
2008-12-12
|
pubmed:meshHeading |
pubmed-meshheading:8191595-Adult,
pubmed-meshheading:8191595-Aged,
pubmed-meshheading:8191595-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8191595-Breast Neoplasms,
pubmed-meshheading:8191595-Carcinoma,
pubmed-meshheading:8191595-Drug Administration Schedule,
pubmed-meshheading:8191595-Female,
pubmed-meshheading:8191595-Humans,
pubmed-meshheading:8191595-Middle Aged,
pubmed-meshheading:8191595-Mitomycin,
pubmed-meshheading:8191595-Treatment Outcome,
pubmed-meshheading:8191595-Vinblastine
|
pubmed:year |
1994
|
pubmed:articleTitle |
Mitomycin "C" and vinorelbine as second line chemotherapy for metastatic breast carcinoma.
|
pubmed:affiliation |
Servizio di Chemioterapia, Ospedale Oncologico M. Ascoli Palermo, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|